Literature DB >> 30478976

When pharmacology meets the microbiome: new targets for therapeutics?

Niall P Hyland1,2, John F Cryan2,3.   

Abstract

LINKED ARTICLES: This article is part of a themed section on When Pharmacology Meets the Microbiome: New Targets for Therapeutics? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.24/issuetoc.
© 2018 The British Pharmacological Society.

Mesh：

Substances：

Year:  2018        PMID： 30478976      PMCID： PMC6255957          DOI： 10.1111/bph.14502

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  15 in total

1.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

Authors:  Zeneng Wang; Adam B Roberts; Jennifer A Buffa; Bruce S Levison; Weifei Zhu; Elin Org; Xiaodong Gu; Ying Huang; Maryam Zamanian-Daryoush; Miranda K Culley; Anthony J DiDonato; Xiaoming Fu; Jennie E Hazen; Daniel Krajcik; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

2.  A Microbial Drugstore for Motility.

Authors:  John F Cryan; Gerard Clarke; Timothy G Dinan; Harriet Schellekens
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

Review 3.  Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration.

Authors:  Timothy G Dinan; John F Cryan
Journal:  J Physiol       Date:  2016-12-04       Impact factor: 5.182

4.  Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.

Authors:  Sofia Cussotto; Conall R Strain; Fiona Fouhy; Ronan G Strain; Veronica L Peterson; Gerard Clarke; Catherine Stanton; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2018-08-28       Impact factor: 4.530

Review 5.  Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.

Authors:  Klytaimnistra Kiouptsi; Christoph Reinhardt
Journal:  Br J Pharmacol       Date:  2018-09-25       Impact factor: 8.739

Review 6.  Phages of life - the path to pharma.

Authors:  Amanda Forde; Colin Hill
Journal:  Br J Pharmacol       Date:  2018-01-03       Impact factor: 8.739

Review 7.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

Review 8.  Psychobiotics: a novel class of psychotropic.

Authors:  Timothy G Dinan; Catherine Stanton; John F Cryan
Journal:  Biol Psychiatry       Date:  2013-06-10       Impact factor: 13.382

9.  Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat.

Authors:  K J Davey; P D Cotter; O O'Sullivan; F Crispie; T G Dinan; J F Cryan; S M O'Mahony
Journal:  Transl Psychiatry       Date:  2013-10-01       Impact factor: 6.222

10.  Extensive impact of non-antibiotic drugs on human gut bacteria.

Authors:  Lisa Maier; Mihaela Pruteanu; Michael Kuhn; Georg Zeller; Anja Telzerow; Exene Erin Anderson; Ana Rita Brochado; Keith Conrad Fernandez; Hitomi Dose; Hirotada Mori; Kiran Raosaheb Patil; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2018-03-19       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.